Drugmakers turn to AI to speed trials, regulatory submissions - News Summed Up

Drugmakers turn to AI to speed trials, regulatory submissions


"Everything else that's around that needs to be as efficient and as small as possible," Teva CEO Richard Francis said. "This is where I think AI digitization, modernization, process improvement, all the unsexy stuff that we get actually quite excited about, makes ​a difference. "What everybody's waiting for is the AI drug. When do I get the AI drug?" "(Reporting by Maggie Fick and Michael Erman from San Francisco; Additional reporting by Bhanvi Satija in London; Editing by Caroline Humer and Bill Berkrot)>


Source: Economic Times January 26, 2026 19:35 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */